eComment. Activated recombinant factor VII in intractable bleeding after cardiac surgery.
作者信息
Hajj-Chahine Jamil
机构信息
Department of Cardio-Thoracic Surgery, University Hospital of Poitiers, Poitiers, France.
出版信息
Interact Cardiovasc Thorac Surg. 2012 Jun;14(6):698. doi: 10.1093/icvts/ivs121.
Abstract
摘要
相似文献
1
eComment. Activated recombinant factor VII in intractable bleeding after cardiac surgery.电子评论。心脏手术后难治性出血中活化的重组凝血因子VII。
Interact Cardiovasc Thorac Surg. 2012 Jun;14(6):698. doi: 10.1093/icvts/ivs121.
2
Successful use of a military haemostatic agent in patients undergoing extracorporeal circulatory assistance and delayed sternal closure.
Interact Cardiovasc Thorac Surg. 2012 Jun;14(6):695-8. doi: 10.1093/icvts/ivs029. Epub 2012 Feb 24.
3
Hemostatic modifications of the Bentall procedure.Bentall手术的止血改良
Tex Heart Inst J. 2012;39(4):604-5; author reply 605.
4
eComment. Further tips on partial sternotomy.电子评论。关于部分胸骨切开术的更多提示。
Interact Cardiovasc Thorac Surg. 2014 Oct;19(4):610. doi: 10.1093/icvts/ivu256.
5
Intraoperative use of recombinant activated factor VII during complex aortic surgery.在复杂主动脉手术中使用重组活化因子 VII。
J Thorac Cardiovasc Surg. 2012 May;143(5):1198-204. doi: 10.1016/j.jtcvs.2012.01.004. Epub 2012 Jan 27.
6
Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.止血复苏的充分性可提高重组活化因子VII的治疗效果，并降低心脏手术后难治性出血患者再次手术止血的发生率。
Ann Card Anaesth. 2019 Oct-Dec;22(4):388-393. doi: 10.4103/aca.ACA_108_18.
7
The hazard of comparing apples and oranges: the proper indication for the use of recombinant activated clotting factor VII in cardiac surgery.将苹果与橙子作比较的危害：重组活化凝血因子VII在心脏手术中的合理应用指征
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1588-9; author reply 1589. doi: 10.1016/j.jtcvs.2011.08.028.
8
eComment: Late wound healing problems after use of BioGlue.电子评论：使用生物胶水后伤口愈合延迟的问题。
Interact Cardiovasc Thorac Surg. 2011 Nov;13(5):535. doi: 10.1510/icvts.2011.276360A.
9
Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.体外膜肺氧合期间用于难治性出血的活化重组凝血因子VII
J Thorac Cardiovasc Surg. 2004 Jun;127(6):1812-3. doi: 10.1016/j.jtcvs.2003.12.021.
10
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes.重症监护病房复杂心血管手术后重组活化因子 VII 的给药：临床和经济结局。
J Thorac Cardiovasc Surg. 2011 Jun;141(6):1469-77.e2. doi: 10.1016/j.jtcvs.2011.02.033. Epub 2011 Mar 31.
本文引用的文献
1
Successful use of a military haemostatic agent in patients undergoing extracorporeal circulatory assistance and delayed sternal closure.
Interact Cardiovasc Thorac Surg. 2012 Jun;14(6):695-8. doi: 10.1093/icvts/ivs029. Epub 2012 Feb 24.
2
Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).重组活化因子 VII 在心血管手术后难治性出血中的超适应证使用：23 家法国心脏中心实践的观察性研究（2005-2007 年）。
Eur J Cardiothorac Surg. 2011 Dec;40(6):1320-7. doi: 10.1016/j.ejcts.2011.03.032. Epub 2011 May 6.
3
A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery.一种新型止血剂：Celox（壳聚糖）在心胸外科手术中的初步挽救生命的经验。
Ann Thorac Surg. 2009 Feb;87(2):e13-4. doi: 10.1016/j.athoracsur.2008.09.046.
4
Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?重组活化因子VII对心脏手术后的难治性出血是否有效？
Interact Cardiovasc Thorac Surg. 2006 Aug;5(4):493-8. doi: 10.1510/icvts.2006.134791. Epub 2006 May 3.
Zotero 插件